Quant firm deploys new metric for Covid sensitivity

Los Angeles Capital debuts new factor for measuring stocks’ sensitivity to the pandemic


Los Angeles Capital Management, the $20 billion global quant equity firm, has instituted a new factor to help it measure the sensitivities of stocks to Covid-19 and more accurately model their economic performance around the pandemic.

“We wanted to develop one metric that would measure a portfolio’s beta to Covid,” says Hal Reynolds, the firm’s chief investment officer. “If Covid subsides without a fall recurrence and the economy recovers quickly, we would expect portfolios with high Covid

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: